» Articles » PMID: 23180141

Analysis of Cytotoxic Activity at Short Incubation Times Reveals Profound Differences Among Annonaceus Acetogenins, Inhibitors of Mitochondrial Complex I

Overview
Publisher Springer
Date 2012 Nov 27
PMID 23180141
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Annonaceous acetogenins are potent cytotoxic agents against tumor cell lines as well as potent inhibitors of mitochondrial Complex I (Degli Esposti and Ghelli Biochim Biophys Acta 1187:116-120, 1994; Degli Esposti et al. Biochem J 301(Pt 1):161-167, 1994; Tormo et al. Arch Biochem Biophys 369:119-126, 1999). Eighteen different ACGs belonging to seven structural sub-families were tested against six tumor and two non tumor cell lines in a MTT cytotoxicity assay to evaluate the correlation between mitochondrial Complex I inhibition and cytotoxic activity potency and selectivity. The results showed a substantial heterogeneity in potency and selectivity among the different compounds tested, although no clear overall structure-activity relationships could be established. To further characterize the biological activity of these compounds, four ACGs were selected based on their inhibition binding sites to Complex I, to evaluate their cytotoxic activity over a 15-minute to 48-hour period using a more sensitive time-course LDH cytotoxicity assay. Our results indicate that, although all of the ACGs were highly cytotoxic in HepG2 cell lines at 24 h, each sub-class behaves rather differently at shorter times. Perhaps other aspects related to how these compounds reach or bind to their target sites, or differences in their ability to cross the cell and/or the mitochondrial membranes, could help explain their different activities. This different behavior between ACGs may provide new clues for a better understanding of their potential antitumor properties.

Citing Articles

: Comprehensive Review on the Ethnomedicinal, Phytochemistry, and Pharmacological Aspects Focusing on Antidiabetic Properties.

Zubaidi S, Mohd Nani H, Ahmad Kamal M, Abdul Qayyum T, Maarof S, Afzan A Life (Basel). 2023; 13(2).

PMID: 36836708 PMC: 9968120. DOI: 10.3390/life13020353.


Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study.

Chang Y, Lin C, Liu T, Huang C, Chung C, Chen Y Arthritis Res Ther. 2022; 24(1):229.

PMID: 36221101 PMC: 9552457. DOI: 10.1186/s13075-022-02917-4.


Mart. Fractions Promote Cell Cycle Arrest and Inhibit Autophagic Flux in Human Cervical Cancer Cell Lines.

Gomes I, Silva-Oliveira R, Oliveira Silva V, Rosa M, Vital P, Barbosa M Molecules. 2019; 24(21).

PMID: 31683835 PMC: 6864525. DOI: 10.3390/molecules24213963.


Extending the Metabolite Diversity of the Endophyte .

Gonzalez-Menendez V, Crespo G, Toro C, Martin J, de Pedro N, Tormo J Metabolites. 2019; 9(10).

PMID: 31546616 PMC: 6835440. DOI: 10.3390/metabo9100197.


Fungal endophytes from arid areas of Andalusia: high potential sources for antifungal and antitumoral agents.

Gonzalez-Menendez V, Crespo G, de Pedro N, Diaz C, Martin J, Serrano R Sci Rep. 2018; 8(1):9729.

PMID: 29950656 PMC: 6021435. DOI: 10.1038/s41598-018-28192-5.


References
1.
Cragg G . Natural product drug discovery and development: the United States National Cancer Institute role. P R Health Sci J. 2002; 21(2):97-111. View

2.
Royo I, DePedro N, Estornell E, Cortes D, Pelaez F, Tormo J . In vitro antitumor SAR of threo/cis/threo/cis/erythro bis-THF acetogenins: correlations with their inhibition of mitochondrial Complex I. Oncol Res. 2003; 13(12):521-8. DOI: 10.3727/000000003108748045. View

3.
Tormo J, Royo I, Gallardo T, Zafra-Polo M, Hernandez P, Cortes D . In vitro antitumor structure-activity relationships of threo/trans/threo mono-tetrahydrofuranic acetogenins: correlations with their inhibition of mitochondrial complex I. Oncol Res. 2004; 14(3):147-54. DOI: 10.3727/000000003771013099. View

4.
Yuan S, Chang H, Chen H, Yeh Y, Kao Y, Lin K . Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway. Life Sci. 2003; 72(25):2853-61. DOI: 10.1016/s0024-3205(03)00190-5. View

5.
Tormo J, DePedro N, Royo I, Barrachina I, Zafra-Polo M, Cuadrillero C . In vitro antitumor structure-activity relationships of threo/trans/threo/trans/erythro bis-tetrahydrofuranic acetogenins: correlations with their inhibition of mitochondrial complex I. Oncol Res. 2005; 15(3):129-38. DOI: 10.3727/096504005776367915. View